secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2024-09-27T23:59:59+00:00
Accession:  0001437749-24-030185
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics awards 235,000 RSUs to CEO MacLean and interim CFO Jin
--------------------------------------------------------------------------

- CEO Alexandra MacLean receives 170,000 RSUs; Interim CFO/COO David Jin receives 65,000 RSUs.
- RSUs vest in four equal installments on 9/30/24, 12/31/24, 9/20/25, and 9/20/26, subject to continued service.
- Settlement deferred until the earlier of Jan 10 after termination of service or a Change in Control.
- Awards granted under the company's 2015 Incentive Plan as amended.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924030185/0001437749-24-030185-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924030185/atxi20240927_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-030185

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer